Video by PCR via YouTube
Go to Source

Luis Ortega Paz interviews Rasha Al-Lamee and Christopher Rajkumar on the results of ORBITA-2 randomized placebo-controlled trial, which were presented at the AHA 2023 Congress in Philadelphia.
In stable angina patients with minimal antianginal medication and objective evidence of ischemia, PCI improved angina symptoms more than a placebo procedure, indicating better angina-related health.

Read more news from #AHA 2023 here:
https://www.pcronline.com/News/Whats-new-on-PCRonline/2023/AHA/AHA-2023-interventional-cardiology-perspective

Go to Source